Fatigue in vasculitis

Not Applicable

Completed

• Conditions: Specialty: Renal disorders, Primary sub-specialty: Renal disorders; UKCRC code/ Disease: Renal and Urogenital/ Other disorders of kidney and ureter; Circulatory System; Vasculitis

• Registration Number: ISRCTN11929227
• Lead Sponsor: niversity of Birmingham

Brief Summary

2018 protocol in https://www.ncbi.nlm.nih.gov/pubmed/30377212 (added 27/09/2019) 2020 results in https://pubmed.ncbi.nlm.nih.gov/33369680/ (added 29/12/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-28
• Study Completion: 2019-03-11
• Last Update Posted: 11 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

1. Age 18 and over
2. A diagnosis of AAV as classified by the European Medicines Agency Algorithm (EMEA)
3. Remission for at least six months on day of consent (defined by BVAS=0 on day of consent AND prednisolone dose <7.5mg for 6 months)
4. Significant fatigue levels (MFI-20 general fatigue score 14 or higher)
5. Ability to understand and complete questionnaires

Exclusion Criteria

1. Inability to provide informed consent
2. Inability or unwillingness to undertake physical activity
3. Co-morbidities identified by clinician, considered to contra-indicate an increase in physical activity

Study & Design

• Study Type: Interventional
• Study Design: Not specified